Viewpoint: Bullish
MIN -1.74%: The cheapest Lithium stock around as some call it with the added kicker or Iron Ore production and a crushing business reported FY22 results today that were all solid, however a revision higher for FY23 Capex guidance saw the stock hit early, before recovering late. That seems to be the typical market reaction to MIN results, there’s always something that needs further explanation and when Managing Director Chris Ellison talks, the market takes note.
ABB -15.29%: a difficult start to the week for the telco which copped the double whammy of a weak market and soft outlook. FY22 was solid but well flagged though EBITDA of $39.4m was slightly ahead of guidance at $39m. The $9.6m contribution from the Over The Wire acquisition completed in the year was slightly below expectations, however, this was…
LOV +6.16%: one of only a handful of medium/large cap stocks to trade higher today against the broader market weakness, rallying on a strong FY22 result with positive outlook commentary. The jewellery retailer was 8% ahead of consensus at the revenue line, printing $459m, up 59% on FY22. EBIT was slightly ahead at $142.5m, and profit more…
The Greenback remains very strong following the hawkish comments from Jerome Powell with a pop towards 2022 highs looking inevitable.
LYC +1.23%: results for FY22 looked like a miss from the rare earths company today, however, shares traded higher on positive growth commentary. Profit was $541m for the year, around a 5% miss to expectations however they have built up a cash balance of $965m putting them in a great position to grow. Construction of their Kalgoorlie processing…
ASB -2.26%: the shipbuilder announced a good set of numbers for their FY22 result today, though it failed to ignite the stock. EBITDA was in line with pre-guided numbers at $120.7m, up 5.3% on the back of the recently awarded OPC contract that could be worth up to $3.3b in revenue. It’s positive to see the new steel shipbuilding facility being put to…
WES +0.65%: A better than expected FY22 results from Wesfarmers today with all key metrics coming in ahead of consensus expectations with net profit after tax around a 5% beat. While FY22 profit was down 1.2% on FY21, that was a result of a tough 1H with 2H earnings growth of 13.1% showing a strong rebound. The 2H dividend of $1 was a beat and…
Metcash (MTS) resides in our Income Portfolio for a couple of easy-to-comprehend reasons:
On the eve of its result this morning RHC finally updated the market on how things were travelling with regard to KKR’s bid for the business, seems a strange time to press the button but it won’t be the last time that a board has made a strange decision – hopefully, they will release a cracker of a result exerting pressure on KKR to pay a nice clean $88. The main takeout’s are:
CAJ +4.84%: the diagnostic imaging company reported FY22 results today, coupled with an accretive acquisition that saw shares trade higher. Revenue grew 3.5%, and although it was down 3.5% in the second half, the fall was less than that implied by Medicare data. EBITDA was down 14% to $41m in line with market expectations. They extended the buyback…
